Urologia, il prof. Giovanni Muto è il nuovo responsabile

"Clinical activity, research and university training: we will move in these three directions to better treat patients and contribute to scientific knowledge", explains the urologist who in Humanitas Gradenigo will use the most advanced technologies to tackle the typical tumors of the aurous apparatus -genital.

Professor Giovanni Muto is the new head of Urology of Humanitas Gradenigo . Fresh from his experience at the helm of Urology at the Campus Bio-Medico University Hospital of Rome, Professor Muto was Head of Urology at the Maria Vittoria Hospital between 1990 and 1998 and Director of Urology at the San Giovanni Bosco Hospital until to 2014. Its name is linked to the invention of two surgical techniques for bladder tumors , both developed in Turin and now adopted all over the world: the " Seminal sparing ", which allows you to maintain sexual potency even in the case of removal of the bladder and the " Turin pouch", Which uses a stretch of the colon to create a sac with the function of a bladder.

Full Professor of Urology at Humanitas University , Director of the Specialty School of Urology at the Campus Bio-Medico University of Rome and adjunct professor at the Faculty of Medicine and Surgery of the Temple University of Philadelphia (United States), Professor Muto brings to Humanitas Gradenigo experience of over 25 thousand urological interventions and about 100 scientific publications resulting from collaboration with some of the main international universities .

« Clinical activity, research and university training will be the roads on which I will work in Humanitas Gradenigo - says Professor Muto -. These are three aspects that the reality of Humanitas considers to be of primary importance and which find a valid example also in the University , young and projected towards the future thanks to its international mentality ».

Apart from the actions of major surgery who delivered the international authority to Professor Muto , the ' Urology of Humanitas Gradenigo will stand for minimally invasive techniques laser that will be used for the removal of prostatic adenomas and bladder cancers as well as for technical laparoscopy to which it will be used for prostate and kidney cancers and for nephrectomies . Activities that will enrich and integrate andrological treatmentsfor impotence, male infertility and the treatment of urinary stones and incontinence already widely established at the hospital's Urology.

The Urology department will also count on the most modern version of the Fusion Biopsy , the technology that merges the images of the magnetic resonance with those of the 3D echograph allows the execution of targeted samples, useful for locating prostate cancer with greater precision in order to to get a more accurate diagnosis . Professor Muto and Dr. Alessandro Giacobbe, now his collaborator in Humanitas Gradenigo , were the first in Piedmont to adopt the Fusion Biopsy, in 2013 at the Fornaca Clinic. Today they will also be used in Humanitas Gradenigo: "We will make our absolute experience available to patients by combining it with the latest generation equipment, essential for recognizing the presence of the disease at an early stage and making it easier to treat the most common male cancer in the Western world ", explain the two urologists .

About 40 percent of solid tumors today are attributable to the uro-genitalsystem . For this reason the ' Urologyof the Humanitas Gradenigo willwork closely with the' Oncology directedby Dr. Alessandro Comandone . Also inthis case, the clinical activity that sees the hospital included within the OncologicalNetwork of Piedmont and Valle d'Aosta , will beaccompanied by scientific research aimedat the study of neoplasms affecting the organs of the urinary and genitaltract.